MID-VOLUME · SEX-BALANCED

doxepin Side Effects

doxepin (also sold as Sinequan, Silenor) sits MID-VOLUME #323 of 524 by FAERS report count. Lead signal: SEX-BALANCED - 69% of sex-coded reports are female (6,137 F / 2,822 M). Demographics and serious-outcome tables follow.

Data updated 2026-05-15

9,780
FAERS reports

FDA Adverse Event Reporting System extract for doxepin. Stamp set WATCHLIST · DEATH-HEAVY · HOSP-MID. How figures are compiled.

doxepin reporting skew - 69% of sex-coded reports are female (6,137 F / 2,822 M). Volume band MID-VOLUME #323 of 524 by FAERS report count; caseload WATCHLIST.

Mid-book FAERS page for doxepin (Sinequan) (9,780 reports). Signature SEX-BALANCED. Dominant age band on file: 45-64. Educational reference only.

Counts from the openFDA FAERS extract (1998–2025). Stamps WATCHLIST · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.

TOXICITY TO VARIOUS AGENTS leads 801 of 9,780 reports

TOXICITY TO VARIOUS AGENTS
801
COMPLETED SUICIDE
613
FATIGUE
599
NAUSEA
557
PAIN
527
HEADACHE
482
PRURITUS
468
DIARRHOEA
431
DYSPNOEA
418
INSOMNIA
417
CHRONIC KIDNEY DISEASE
408
DIZZINESS
405
ANXIETY
401
DEPRESSION
392
FALL
382
URTICARIA
365
DEATH
363
DRUG INTERACTION
330

Who reports · age peak 45-64 (SEX-BALANCED)

Sex coding · SEX-BALANCED

Female 6,137 (68%)
Male 2,822 (31%)
Unknown 38

Age peak 45-64 (2,890 reports)

0-17 197 (3%)
18-44 1,803 (27%)
45-64 2,890 (43%)
65-74 998 (15%)
75+ 756 (11%)

FAERS filings rising toward 2025

1998 2025

Reactions in Death Reports

Death-mentioned subset is HEAVY here (1,746 reports, 17.9%). Top co-reported reactions in that subset - voluntary, not causal.

Reaction Reports
COMPLETED SUICIDE 613
TOXICITY TO VARIOUS AGENTS 591
DEATH 363
DRUG ABUSE 201
CARDIO-RESPIRATORY ARREST 156
OVERDOSE 79
PULMONARY OEDEMA 70
CARDIAC ARREST 67
BRAIN OEDEMA 54
DRUG INTERACTION 52
NAUSEA 50
RESPIRATORY ARREST 48
FATIGUE 47
RESPIRATORY DEPRESSION 46
INTENTIONAL OVERDOSE 42
ACUTE KIDNEY INJURY 40
SUSPECTED SUICIDE 38
HYPOTENSION 37
DEPRESSED LEVEL OF CONSCIOUSNESS 36
PAIN 36

Reactions in Hospitalization Reports

Hospitalization mid-share (2,865, 29.3%). Co-reported reactions:

Reaction Reports
TOXICITY TO VARIOUS AGENTS 278
FALL 216
NAUSEA 211
DYSPNOEA 208
FATIGUE 193
PAIN 176
DIARRHOEA 171
ASTHENIA 169
DRUG INTERACTION 164
HEADACHE 163
DIZZINESS 159
VOMITING 152
PNEUMONIA 151
COMPLETED SUICIDE 140
WEIGHT DECREASED 136
DEPRESSION 133
INSOMNIA 127
PAIN IN EXTREMITY 125
How to read doxepin FAERS figures (WATCHLIST · DEATH-HEAVY · HOSP-MID)

FAERS holds 9,780 voluntary reports linked to doxepin (Sinequan, Silenor), 1998-2025. Death is listed on 1,746 (17.9%). Hospitalization appears on 2,865 (29.3%). Top co-reported indication: Product Used For Unknown Indication.

Mid-volume extract - treat DEATH-HEAVY · HOSP-MID as signal-detection rates next to 69% of sex-coded reports are female (6,137 F / 2,822 M).

Read with doxepin

Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-MID stamps.